MEBO Group extends warm congratulations to its strategic partner, Shandong Medical and Pharmaceutical University, on its official upgrade and renaming from Binzhou Medical University, as announced by the Shandong Provincial Government on March 17, 2026. This milestone marks a significant step forward in the university’s development and creates a higher-level platform for deepened collaboration.

The partnership between MEBO Group and the university is rooted in strong alumni ties. Founder Rongxiang Xu and Professor Li Li are both alumni, forming a lasting foundation of trust and shared vision.

Since 2017, the two sides have built a comprehensive collaboration spanning education, research, and public welfare. The “MEBO International Class” has become a model for integrated clinical training, combining academic learning with hands-on practice. In research, joint initiatives such as the Rongxiang Building and the Regenerative Medicine Research Center have strengthened innovation capacity.

Looking ahead, MEBO Group will further expand cooperation with Shandong Medical and Pharmaceutical University, advancing regenerative medicine research, interdisciplinary talent development, and global health solutions.

About MEBO

Founded in 1987 by Professor Rongxiang Xu, a distinguished Chinese life scientist, MEBO Group is a multinational headquartered in both China and the USA. It integrates research, development, and sales across the pharmaceuticals, medical devices, health foods, and cosmetics sectors.

At its core, MEBO focuses on regenerative life sciences, innovating with over 100 patents and more than ten joint research bases to enhance and enable the body's own regenerative abilities.

As a leader in regenerative life science, MEBO's extensive research facilities and products impact over 100 countries globally, pioneering new frontiers in the regenerative life world.